Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Donald Trump to surrender to New York prosecutors on Tuesday
    • Vladimir Putin’s new doctrine calls US ‘main source’ of threat to Russian security
    • Pro-Trump protesters fail to show up in New York
    • Ron DeSantis falls in line with Republicans in closing ranks behind Donald Trump
    • ‘Dare to fight’: Xi Jinping unveils China’s new world order
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Banks in turmoil
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • UBS shortlists four consultants for Credit Suisse integration
      • Mis-steps that brought Virgin Orbit crashing back to earth
      • EY bosses present united front after dispute over stalled break-up plan
      • ThyssenKrupp revives sale of submarine and marine systems unit
      • Deep-sea mining is key to making transition to clean energy, says Loke
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • Prepare for a multipolar currency world
      • Bond markets are still skittish — but they have reason to be
      • Deep-sea mining is key to making transition to clean energy, says Loke
      • Nasdaq records best quarter since 2020 after volatile start to year
      • Flood of cash into US money market funds could add to banking strains
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
      Most Read
      • Why are Americans dying so young?
      • We are living through a trillion-dollar rebalancing
      • Prepare for a multipolar currency world
      • Bond markets are still skittish — but they have reason to be
      • Where did all the reactionaries go?
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      Most Read
      • Boomerang chief executives provide comfort in times of crisis
      • Matthew Desmond: ‘America does so much more to subsidise affluence than alleviate poverty’
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • Serhiy Prytula: ‘The defence minister said: “Try to buy a satellite.” I thought he was joking’
      • Homebuyers chase their European dreams despite economic outlook
      • Essay: Is being a perfectionist really a bad thing?
      • I used AI to bet on horse-racing. Here’s what happened
      • Hamnet reborn: a pandemic bestseller moves from page to stage
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    US opioid epidemic

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Sunday, 12 March, 2023
      News in-depthMexico
      US turns up heat on Mexico after cartel kidnappings

      Deaths of US citizens and steeply rising fentanyl casualties prompt rising frustration in Washington

    • Monday, 20 February, 2023
      News in-depthFT Investigations
      Oxford university stuck with Sacklers as opioid deaths led others to cut ties

      Documents show privileged access to the Boat Race and continued acceptance of donations

    • Sunday, 22 January, 2023
      US warns overdose crisis will spread overseas without action from China

      White House drugs tsar says Beijing needs to tighten rules on supply of raw materials to make fentanyl

    • Thursday, 19 January, 2023
      The Oscars 2023: all you need to know
      Laura Poitras on Nan Goldin and their film taking on the opioid crisis

      The director discusses the fight to expose the Sackler family’s ‘artwashing’ of a fortune built on addictive drugs

    • Thursday, 29 December, 2022
      AmerisourceBergen slapped with federal lawsuit over opioids crisis

      Drug distributor knew pills were likely being sold in parking lots for cash, allege prosecutors

    • Tuesday, 15 November, 2022
      Walmart Inc
      Walmart lifts guidance as richer consumers go bargain hunting

      Retailer upgrades outlook even as $3.1bn opioids settlement results in quarterly net loss

    • Tuesday, 8 November, 2022
      US to boost medication access to tackle opioid overdose crisis

      Legal, societal and financial barriers block treatments that can reduce risk of overdose

    • Wednesday, 2 November, 2022
      US pharmacy groups CVS and Walgreens agree $10bn opioid settlements

      Other chains also in talks over claims linked to their roles in crisis

    • Thursday, 8 September, 2022
      Edward Luce
      America’s indifference to its death crisis

      The enduring drivers of the country’s morbid trajectory — rising obesity, the opioid epidemic and Covid — are hard to confront

    • Monday, 5 September, 2022
      Venice Film Festival 2022
      Five stars for opioid epidemic documentary All the Beauty and the Bloodshed

      Laura Poitras’s film is both a biography of artist Nan Goldin and an indictment of the Sackler family

    • Friday, 26 August, 2022
      Data PointsJohn Burn-Murdoch
      How US life expectancy fell off a cliff

      One factor explains why a gulf has opened between America and its wealthy peers: deaths from drug overdoses

    • Wednesday, 15 June, 2022
      InterviewOffice of National Drug Control Policy
      US pivots to ‘harm reduction’ after 107,000 overdose deaths last year

      White House drug tsar says marijuana legalisation and safe injection sites will also be reviewed

    • Wednesday, 27 April, 2022
      Pharmaceuticals sector
      McKinsey rebuts conflict claims over work for health regulator and opioid makers

      Congressional probe found 22 consultants had advised both the US FDA and drug manufacturers over a decade

    • Thursday, 3 March, 2022
      Purdue Pharma LP
      Purdue and US states agree new $6bn settlement for opioid litigation

      Members of Sackler family who owned OxyContin maker will increase financial contribution but still receive a legal shield

    • Friday, 18 February, 2022
      Sackler owners offer up to $6bn to settle Purdue Pharma bankruptcy

      Proposal revealed by court mediator comes after a judge rejected earlier deal

    • Wednesday, 16 February, 2022
      LexIndivior PLC
      Indivior: opioid treatment specialist is out of rehab Premium content

      The pharmaceuticals company has returned to financial health and is exploring a dual UK-US listing

    • Tuesday, 4 January, 2022
      The Big Read
      Will overdose deaths force an end to the US ‘war on drugs’?

      With more than 270 people dying every day, authorities are under pressure to treat, rather than prosecute, users

    • Friday, 17 December, 2021
      Judge overturns $4.5bn opioid-related settlement in Purdue Pharma bankruptcy

      Sackler family was to make multibillion-dollar contribution in exchange for protection from lawsuits

    • Thursday, 9 December, 2021
      Sackler name to be removed from Metropolitan Museum of Art galleries

      Move is the latest fallout for members of the family that owned opioid maker Purdue Pharma

    • Tuesday, 23 November, 2021
      Federal jury finds US pharmacy chains liable for opioid epidemic

      Ohio ruling is first time CVS, Walgreens and Walmart have been held culpable at conclusion of a trial

    • Friday, 12 November, 2021
      US Food & Drug Administration
      Biden’s nominee to lead FDA encounters pushback from some Democrats

      Concerns raised over Robert Califf’s previous stint at the US drugs regulator and its approach to the opioid epidemic

    • Thursday, 4 November, 2021
      InterviewTelevision
      ‘We’ve been screaming’: the makers of Dopesick on reframing the opioid crisis

      Writer Beth Macy and director Barry Levinson discuss taking on the Sacklers and victim-blaming in their mini-series

    • Wednesday, 1 September, 2021
      Purdue Pharma LP
      Sacklers shielded from future lawsuits in Purdue settlement

      Judge approves bankruptcy plan for opioid maker in which family will pay $4.5bn

    • Sunday, 8 August, 2021
      News in-depth
      Purdue’s bankruptcy deal shields Sackler family owners from future opioid liability

      Critics say concessions in case regarding the company diminishes accountability in overdose scandal

    • Wednesday, 21 July, 2021
      States unveil $26bn settlement to resolve opioid lawsuits

      US attorneys-general announce agreement with Johnson & Johnson and drug distribution giants

    Previous page You are on page 1 Next page

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsSecondary Schools

    Tools

    PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition

    Top sections

    • Home
    • World
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
      • Australia & NZ
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Banks in turmoil
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports

    FT recommends

    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • FTfm
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today's Newspaper (ePaper)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In